Filter Results:
(123)
Show Results For
- All HBS Web (123)
- Faculty Publications (10)
Show Results For
- All HBS Web (123)
- Faculty Publications (10)
- 01 Mar 2024
- News
Alumni and Faculty Books and Podcasts
will solve real problems, from climate change and hunger to obesity and menstrual pain. They envision a future in which biotechnologists work from a platform that enables them to develop effective drugs within months for any emerging... View Details
- 21 Oct 2015
- Research & Ideas
How to Predict if a New Business Idea is Any Good
industry like drug development, it’s not like you can just switch from one disease to another disease,” she says. While R&D-intensive ventures can shift the application of their underlying technology, Shu continues, the fact they are... View Details
- 25 Aug 2003
- Research & Ideas
Why IT Does Matter
Radio-frequency identification devices for grocery stores, smart cards, and automated ordering systems for hospital physicians are all examples of new process targets that technologies will soon address. In the more distant future we will see the improved creation of... View Details
Keywords: by F. Warren McFarlan & Richard L. Nolan
- 05 Jul 2006
- Research & Ideas
The Accidental Innovator
direct special attention to it." Similarly, Daguerre, who invented photography, made his breakthrough when he put an exposed plate into a cabinet in which a thermometer had earlier shattered; mercury vapors from the broken... View Details
Keywords: by Sarah Jane Gilbert
- Web
Industry Information - Alumni
biotechnology, drug discovery technologies, clinical diagnostics, healthcare IT, medical imaging, and medical devices, and provide local expertise along with a global perspective. BioSpace Leading online community for industry news and... View Details
- 19 Sep 2016
- Research & Ideas
Why Isn't Business Research More Relevant to Business Practitioners?
disciplines, where academic research is leading to the development of a second skin that could improve drug delivery or alerting farmers and scientists on how to reduce nitrous oxide emissions from agricultural farming. Harvard Business... View Details
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
Now that scientists have mapped the human gene, can drug makers map a road to unlimited riches? For John Lechleiter, Executive Vice President of Eli Lilly and Company's Pharmaceutical Products and Corporate Development, there remain more... View Details
Keywords: by Sean Silverthorne
- Fast Answer
Biotech and Pharmaceuticals: R&D spending, production cost
Where to find biotech and pharmaceuticals R&D spending and product cost data? Bloomberg – use BI function to locate R&D spending data Cortellis - special database on pharmaceuticals industry including R&D... View Details
- Student-Profile
Olivia Zhao
the social sciences were very appealing to me. Also, all the questions I found most interesting were being studied there by economists, so I wanted to learn how to use their methods to make meaning out of data. “As for why I chose to View Details
- 01 Sep 2004
- News
American Dream
visitors in their tracks. “I wonder if I should turn him down a little,” Hustead muses. As president of Wall Drug in Wall, South Dakota, Hustead ponders this and many other details of a 76,000-square-foot roadside attraction, not far from... View Details
- 01 Mar 2017
- News
Alumni Take Cold Calls in New York City
Alumni gathered in New York City in November for a dynamic case discussion — a special benefit for members of the HBS Fund Investors Society. John Quelch, the Charles Edward Wilson Professor of Business Administration at HBS, joined... View Details
- Web
Harvard Business School Announces Its 2024-2025 Blavatnik Fellows - MBA
Blog Blog MBA Voices Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Career and Professional Development Staff Author HBS Community Author HBS Faculty Author MBA Admissions Author MBA Students Topics Topics 1st Year (RC) 2+2 Program 2nd Year... View Details
- 01 Sep 2008
- News
In Africa, Porter Sees Lessons for Health Care
practices to understand principles,” Porter has said. As part of that effort, and emerging from his trip, Porter and several GHD colleagues have written a case study, “HIV Care in Rwanda,” that was the subject of a special seminar at HBS... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
- 10 Sep 2008
- Research & Ideas
Long-Tail Economics? Give Me Blockbusters!
you can make money in many creative industries by selling specialized products to niche markets identified via the Internet. For example, the new CEO of GlaxoSmithKline, the pharmaceuticals giant, likens the search for blockbusters to... View Details
- 01 Jun 2000
- News
The Business of Biotech
biotechnology. The prospect is exhilarating, but the road to this brave new biotech world has more than a few bumps. With an average time line of ten years required to bring a drug to market - and the potential for failure looming every... View Details
Keywords: Julia Hanna
- 05 May 2020
- News
“Walking a Tightrope”
Kristof, most of which have focused on poverty in developing countries. But in the Pulitzer Prize-winning duo’s latest book, Tightrope: Americans Reaching for Hope, they turn their lens on working class communities in the United States—communities that have been... View Details
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
targeted approach gives Bennet hope that Harmoni can benefit not only people suffering from movement disorders, but also a whole class of psychiatric patients who, until now, had few options beyond prescription drugs to help lessen the... View Details
Keywords: Janelle Nanos
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
counterpart at Honeywell, Michael Bonsignore, were rushing to close the deal (United Technologies was also eager to acquire Honeywell), they "reportedly never held initial consultations with their Brussels lawyers who specialize in... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
investment in math and physical sciences. Moving on to challenges Merck has faced, Gilmartin explained that new drug discovery tools have increased the speed at which its competitors can introduce new products to the marketplace, even as... View Details